Five minutes after intramuscular epinephrine, a child is still wheezing and hypotensive. Should you wait longer, try albuterol, or give another epinephrine dose? When airway, breathing, or circulation problems persist, repeat IM epinephrine now while addressing shock. One dose without a full response is not yet “refractory anaphylaxis” under the common two-dose definition—but it is not a reason to delay.
The key is persistent ABC compromise, not residual hives
Consider a 10-year-old, 32-kg boy with a known peanut allergy who develops hives, lip swelling, and wheezing shortly after eating a cookie at school. His blood pressure is 88/50 mmHg. After an appropriate first IM epinephrine dose, he remains wheezy five minutes later and his systolic pressure is 85 mmHg.
The rapid onset after a known allergen, skin and mucosal findings, respiratory symptoms, and low blood pressure support anaphylaxis. At age 10, a systolic pressure of 85 mmHg is below the age-specific hypotension threshold used in pediatric emergency pathways. Persistent wheeze and hypotension are ongoing breathing and circulation problems—not just a rash that has yet to fade.
| Reassessment finding | What it suggests | Immediate implication |
|---|---|---|
| Persistent wheeze, increased work of breathing, hypoxemia, or hypotension | Ongoing airway, breathing, or circulation compromise | Repeat IM epinephrine; support ABCs |
| Mild residual hives after breathing and circulation have stabilized | Skin symptoms may outlast more dangerous features | Reassess and monitor; hives alone do not establish persistent ABC compromise |
| Fast pulse or tremor without worsening ABC findings | Could reflect the reaction, distress, or epinephrine’s expected effects | Judge response by breathing and perfusion, not heart rate alone |
If he also has asthma, it can complicate interpretation of wheeze, but it does not explain this child’s sudden hives, lip swelling, and hypotension after peanut exposure. If asthma is part of his history, assess control after stabilization; this case gives too little baseline symptom or medication history to call it poorly controlled. That uncertainty should not delay treatment of the acute reaction.
Act in parallel
At the five-minute reassessment, give another age- and weight-appropriate IM epinephrine dose into the anterolateral thigh. For a 32-kg child who received a 0.3-mg autoinjector dose, many U.S. pediatric pathways use that dose band; follow the dose and interval in the local protocol. Do not wait for IV access before repeating epinephrine.
At the same time, call for resuscitation support, apply oxygen and cardiorespiratory monitoring, and prepare IV or IO access. Keep the child lying flat if tolerated, with legs elevated when appropriate. If lying flat worsens respiratory distress, allow a more comfortable semi-recumbent position; do not have the child stand or walk during the acute reaction.
Low blood pressure calls for prompt isotonic crystalloid resuscitation as well as epinephrine. Anaphylaxis can reduce effective circulating volume through vasodilation and fluid leaving the bloodstream. Bolus volumes differ between protocols: for example, one guideline uses 10 mL/kg and a U.S. children’s hospital pathway uses 20 mL/kg. For this 32-kg child, those amounts are 320 mL and 640 mL, respectively. Use the local pathway, then reassess blood pressure, perfusion, respiratory status, and the need for further fluid rather than treating one calculated volume as universal.
Albuterol may help persistent lower-airway bronchospasm, particularly when asthma is also present, but it is an adjunct—not a substitute for epinephrine. Antihistamines may help skin symptoms after initial stabilization; they do not reverse hypotension or treat life-threatening respiratory compromise. Neither antihistamines nor corticosteroids should delay repeat epinephrine or fluid resuscitation.
Name severity carefully—and know when to escalate
Persistent symptoms after one appropriate IM dose call for prompt treatment and help; they do not, by themselves, meet the usual definition of refractory anaphylaxis. Resuscitation Council UK defines refractory anaphylaxis by lack of improvement in respiratory or cardiovascular symptoms despite two appropriate IM doses.
If respiratory or cardiovascular problems have not improved after two appropriate doses, involve experienced resuscitation and critical-care clinicians early. A monitored epinephrine infusion may be needed; IV epinephrine boluses carry additional risk and are not routine treatment outside specialist-directed circumstances or cardiac-arrest protocols. Continue reassessment and follow local escalation guidance.
A common trap is to treat a rising heart rate after epinephrine as proof that the medicine is causing deterioration. Tremor and palpitations can occur, but the decision to repeat treatment rests on the child’s airway, breathing, circulation, and overall trajectory. Another trap is calling persistent symptoms a biphasic reaction: biphasic reactions recur after the initial symptoms have resolved, without re-exposure. Ongoing symptoms five minutes after treatment are a different problem.
Practical takeaways
- Persistent breathing or circulation problems five minutes after IM epinephrine call for another dose—not a wait for adjuncts.
- Treat the child’s whole pattern: wheeze plus hives and hypotension after known food exposure is not an isolated asthma flare.
- For hypotension, arrange IV or IO access and give isotonic crystalloid while continuing epinephrine; use the local bolus protocol and reassess.
- The common two-dose definition of refractory anaphylaxis requires no improvement in respiratory or cardiovascular symptoms despite two appropriate IM doses; escalate to expert, monitored care.
